BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hijdra D, Vorselaars AD, Crommelin HA, van Moorsel CH, Meek B, Claessen AM, Rijkers GT, Grutters JC. Can intermediate monocytes predict response to infliximab therapy in sarcoidosis? Eur Respir J 2016;48:1242-5. [PMID: 27390275 DOI: 10.1183/13993003.00709-2016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Kahlmann V, Janssen Bonás M, Moor CC, van Moorsel CHM, Kool M, Kraaijvanger R, Grutters JC, Overgaauw M, Veltkamp M, Wijsenbeek MS; Collaborating investigators. Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study. BMC Pulm Med 2020;20:271. [PMID: 33076885 DOI: 10.1186/s12890-020-01290-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
2 Wahlund CJE, Gucluler Akpinar G, Steiner L, Ibrahim A, Bandeira E, Lepzien R, Lukic A, Smed-Sörensen A, Kullberg S, Eklund A, Grunewald J, Gabrielsson S. Sarcoidosis exosomes stimulate monocytes to produce pro-inflammatory cytokines and CCL2. Sci Rep 2020;10:15328. [PMID: 32948789 DOI: 10.1038/s41598-020-72067-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
3 Kraaijvanger R, Janssen Bonás M, Vorselaars ADM, Veltkamp M. Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects. Front Immunol 2020;11:1443. [PMID: 32760396 DOI: 10.3389/fimmu.2020.01443] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
4 Nunes H, Jeny F, Bouvry D, Uzunhan Y, Valeyre D. Indications for treatment of sarcoidosis. Curr Opin Pulm Med 2019;25:505-18. [PMID: 31365385 DOI: 10.1097/MCP.0000000000000604] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
5 Kullberg S, Rivera NV, Abo Al Hayja M, Grunewald J, Eklund A. Changes in lung immune cells related to clinical outcome during treatment with infliximab for sarcoidosis. Clin Exp Immunol 2020;201:85-93. [PMID: 32275772 DOI: 10.1111/cei.13438] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
6 Kishimoto I, Nguyen CTH, Kambe N, Ly NTM, Ueki Y, Ueda-Hayakawa I, Okamoto H. Circulating intermediate monocytes produce TARC in sarcoidosis. Allergol Int 2020;69:310-2. [PMID: 31662224 DOI: 10.1016/j.alit.2019.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Torres-Ruiz J, Carrillo-Vazquez DA, Padilla-Ortiz DM, Vazquez-Rodriguez R, Nuñez-Alvarez C, Juarez-Vega G, Gomez-Martin D. TLR expression in peripheral monocyte subsets of patients with idiopathic inflammatory myopathies: association with clinical and immunological features. J Transl Med 2020;18:125. [PMID: 32164729 DOI: 10.1186/s12967-020-02290-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
8 Schreurs I, Meek B, Hijdra D, van Moorsel CHM, Luijk HD, Kwakkel-van Erp JM, Oudijk E, van Kessel DA, Grutters JC. Lung Transplantation Has a Strong Impact on the Distribution and Phenotype of Monocyte Subsets. Transplant Proc 2020;52:958-66. [PMID: 32146023 DOI: 10.1016/j.transproceed.2020.01.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Adler BL, Wang CJ, Bui T, Schilperoort HM, Armstrong AW. Anti-tumor necrosis factor agents in sarcoidosis: A systematic review of efficacy and safety. Seminars in Arthritis and Rheumatism 2019;48:1093-104. [DOI: 10.1016/j.semarthrit.2018.10.005] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
10 Mirjam K, Broos CE. Immunological Manifestations in Sarcoidosis. Sarcoidosis 2019. [DOI: 10.1016/b978-0-323-54429-0.00003-3] [Reference Citation Analysis]